Polybromo1 (PBRM1) is a chromatin remodeler subunit highly mutated in cancer, particularly clear cell renal carcinoma. PBRM1 is a member of the SWI/SNF subcomplex, PBAF (PBRM1-Brg1/Brm-associated factors), and is characterized by six tandem bromodomains. Here we establish a role for PBRM1 in epithelial cell maintenance through the expression of genes involved in cell adhesion, metabolism, stress response, and apoptosis. In support of a general role for PBRM1 in stress response and apoptosis, we observe that loss of PBRM1 results in an increase in reactive oxygen species generation and a decrease in cellular viability under stress conditions. We find that loss of PBRM1 promotes cell growth under favorable conditions but is required for cell ...
Ribonucleotide reductase small subunit B (RRM2B) is a stress response protein that protects normal h...
PBRM1, a component of the chromatin remodeller SWI/SNF, is often deleted or mutated in human cancers...
Klarzellkarzinom ist ein eine Tumorart, die spezifische Mutationen von Genen benötigt, die alle am 3...
DNA organization is an intricate and dynamic process. The approximately two meters of DNA in a singl...
Polybromo-1 (PBRM1) is a component of the PBAF (Polybromo-associated-BRG1- or BRM-associated factors...
<div><p>Polybromo-1 (PBRM1) is a component of the PBAF (Polybromo-associated-BRG1- or BRM-associated...
PBRM1 is a novel tumor suppressor gene that can inhibit cancer cell proliferation and predict the ou...
Summary: PBRM1, a subunit of the PBAF coactivator complex that transcription factors use to activate...
In this study, we investigated the mechanisms by which PBRM1 functions as a tumor suppressor in clea...
The alterations of the SWI/SNF chromatin remodelling complex subunits happen in 30% of malignancies....
PBRM1, a component of the chromatin remodeller SWI/SNF, is often deleted or mutated in human cancers...
Polybromo-1 (PBRM1) is an important tumor suppressor in kidney cancer. It contains six tandem bromod...
PBRM1, a component of the chromatin remodeller SWI/SNF, is often deleted or mutated in human cancers...
Inactivation of the VHL (Von Hippel Lindau) tumour suppressor has long been recognised as necessary ...
Polybromo‐1 (PBRM1) is an important tumor suppressor in kidney cancer. It contains six tandem bromod...
Ribonucleotide reductase small subunit B (RRM2B) is a stress response protein that protects normal h...
PBRM1, a component of the chromatin remodeller SWI/SNF, is often deleted or mutated in human cancers...
Klarzellkarzinom ist ein eine Tumorart, die spezifische Mutationen von Genen benötigt, die alle am 3...
DNA organization is an intricate and dynamic process. The approximately two meters of DNA in a singl...
Polybromo-1 (PBRM1) is a component of the PBAF (Polybromo-associated-BRG1- or BRM-associated factors...
<div><p>Polybromo-1 (PBRM1) is a component of the PBAF (Polybromo-associated-BRG1- or BRM-associated...
PBRM1 is a novel tumor suppressor gene that can inhibit cancer cell proliferation and predict the ou...
Summary: PBRM1, a subunit of the PBAF coactivator complex that transcription factors use to activate...
In this study, we investigated the mechanisms by which PBRM1 functions as a tumor suppressor in clea...
The alterations of the SWI/SNF chromatin remodelling complex subunits happen in 30% of malignancies....
PBRM1, a component of the chromatin remodeller SWI/SNF, is often deleted or mutated in human cancers...
Polybromo-1 (PBRM1) is an important tumor suppressor in kidney cancer. It contains six tandem bromod...
PBRM1, a component of the chromatin remodeller SWI/SNF, is often deleted or mutated in human cancers...
Inactivation of the VHL (Von Hippel Lindau) tumour suppressor has long been recognised as necessary ...
Polybromo‐1 (PBRM1) is an important tumor suppressor in kidney cancer. It contains six tandem bromod...
Ribonucleotide reductase small subunit B (RRM2B) is a stress response protein that protects normal h...
PBRM1, a component of the chromatin remodeller SWI/SNF, is often deleted or mutated in human cancers...
Klarzellkarzinom ist ein eine Tumorart, die spezifische Mutationen von Genen benötigt, die alle am 3...